Evidence map›Paper›PMID 39152479›Full record

ArticleJournal of medical case reports2024

Prostate ductal adenocarcinoma exhibiting a late recurrence in the anterior urethra 13 years post-total prostatectomy: a case report.

Seiichiro Honda, Takashi Kawahara, Reiko Tanaka, Shu Yuguchi, Shoji Yamanaka, Satoshi Fujii, Akihito Hasizume, Kimito Osaka, Noboru Mimura, Jurii Karibe and 7 more

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of medical case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Seiichiro HondaDepartment of Urology and Renal Transplantation, Yokohama City University Medical Center, Yokohama, Japan.
Takashi KawaharaDepartment of Urology and Renal Transplantation, Yokohama City University Medical Center, Yokohama, Japan. takashi_tk2001@yahoo.co.jp.ORCID http://orcid.org/0000-0002-7049-3379
Reiko TanakaDepartment of Pathology, Yokohama City University Medical Center, Yokohama, Japan.
Shu YuguchiDepartment of Pathology, Yokohama City University Medical Center, Yokohama, Japan.
Shoji YamanakaDepartment of Pathology, Yokohama City University Hospital, Yokohama, Japan.
Satoshi FujiiDepartment of Molecular Pathology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Akihito HasizumeDepartment of Urology and Renal Transplantation, Yokohama City University Medical Center, Yokohama, Japan.
Kimito OsakaDepartment of Urology and Renal Transplantation, Yokohama City University Medical Center, Yokohama, Japan.
Noboru MimuraDepartment of Urology and Renal Transplantation, Yokohama City University Medical Center, Yokohama, Japan.
Jurii KaribeDepartment of Urology and Renal Transplantation, Yokohama City University Medical Center, Yokohama, Japan.
Takeaki NoguchiDepartment of Urology and Renal Transplantation, Yokohama City University Medical Center, Yokohama, Japan.
Kota ShimokiharaDepartment of Urology and Renal Transplantation, Yokohama City University Medical Center, Yokohama, Japan.
Daiji TakamotoDepartment of Urology and Renal Transplantation, Yokohama City University Medical Center, Yokohama, Japan.
Teppei TakeshimaDepartment of Urology and Renal Transplantation, Yokohama City University Medical Center, Yokohama, Japan.
Jun-Ichi TeranishiDepartment of Urology and Renal Transplantation, Yokohama City University Medical Center, Yokohama, Japan.
Kazuhide MakiyamaDepartment of Urology, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
Hiroji UemuraDepartment of Urology and Renal Transplantation, Yokohama City University Medical Center, Yokohama, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundProstate ductal adenocarcinoma, a rare histology observed in 0.4-0.8% of all prostate cancers, is treated similarly to acinar adenocarcinoma but tends to have a higher likelihood of metastasis, recurrence, and poorer prognosis. CASE PRESENTATION: A 73-year-old Asian-Japanese male presented with gross hematuria, with investigations revealing a prostate ductal adenocarcinoma. Subsequent radical prostatectomy indicated a Gleason score of 8 with no lymph node metastasis. Despite initial prostate-specific antigen level reductions post-prostatectomy and salvage radiation therapy due to recurring elevated prostate-specific antigen levels, no recurrence was evident until 13 years later. A tumor in the anterior urethra was identified as metastasis of his prostate ductal adenocarcinoma.

conclusionThis report presents an uncommon case of prostate ductal adenocarcinoma exhibiting a late recurrence in the anterior urethra 13 years post-radical prostatectomy.

Indexed as

Neoplasm Recurrence, LocalProstatectomyProstatic NeoplasmsUrethral NeoplasmsAdenocarcinomaAgedCarcinoma, DuctalHumansMaleProstate-Specific AntigenProstate-Specific AntigenProstate ductal adenocarcinomaUrethral cancerUrethral carcinoma

Identifiers

PMID39152479
PMCPMC11330126

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.